Speedway Scene reporting, analysis and commentary on obesity, pulled together from across our coverage.
On July 1 Medicare began covering obesity drugs for the first time in more than two decades, offering eligible enrollees Wegovy, Zepbound and Foundayo for a flat $50 monthly copay, a milestone shadowed by disputes over price, durability and who ultimately benefits.
Everything Speedway Scene has published on obesity, gathered in one place: the reporting, the analysis and the commentary that track the subject.
The developments in markets, business and world affairs that will set the day, distilled into one authoritative email.
